Doraiswamy, P. M., Coleman, R. E., Petrella, J. R., Sheldon, F., Pontecorvo, M. J., Hefti, F., … Clark, C. M. (2010). In Cognitively Healthy and Mildly Impaired Individuals Florbetapir F 18 PET Measures of Amyloid Deposition Correlate with the Degree of Functional Impairment Assessed Six Months Later. In NEUROLOGY (Vol. 74, pp. A338–A338). Toronto, CANADA: LIPPINCOTT WILLIAMS & WILKINS.

Doraiswamy, P Murali, R Edward Coleman, Jeffrey R. Petrella, Forrest Sheldon, Michael J. Pontecorvo, Franz Hefti, Alan Carpenter, Daniel M. Skovronsky, and Christopher M. Clark. “In Cognitively Healthy and Mildly Impaired Individuals Florbetapir F 18 PET Measures of Amyloid Deposition Correlate with the Degree of Functional Impairment Assessed Six Months Later.” In NEUROLOGY, 74:A338–A338. LIPPINCOTT WILLIAMS & WILKINS, 2010.

Doraiswamy PM, Coleman RE, Petrella JR, Sheldon F, Pontecorvo MJ, Hefti F, et al. In Cognitively Healthy and Mildly Impaired Individuals Florbetapir F 18 PET Measures of Amyloid Deposition Correlate with the Degree of Functional Impairment Assessed Six Months Later. In: NEUROLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2010. p. A338–A338.

Doraiswamy, P. Murali, et al. “In Cognitively Healthy and Mildly Impaired Individuals Florbetapir F 18 PET Measures of Amyloid Deposition Correlate with the Degree of Functional Impairment Assessed Six Months Later.” NEUROLOGY, vol. 74, no. 9, LIPPINCOTT WILLIAMS & WILKINS, 2010, pp. A338–A338.

Doraiswamy PM, Coleman RE, Petrella JR, Sheldon F, Pontecorvo MJ, Hefti F, Carpenter A, Skovronsky DM, Clark CM. In Cognitively Healthy and Mildly Impaired Individuals Florbetapir F 18 PET Measures of Amyloid Deposition Correlate with the Degree of Functional Impairment Assessed Six Months Later. NEUROLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2010. p. A338–A338.